Company
Management
Board of Directors
Scientific Advisory Board
Technologies
Pipeline
Career
News
Contact
Company
Management
Board of Directors
Scientific Advisory Board
Technologies
Pipeline
Career
News
Contact
News
Select a year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2026
June 11, T-CURX non-viral Siglec-6 lead CAR-T program, TCX-001, was approved for First-in-Human Phase 1 clinical trial in patients with relapsed/refractory AML and CLL
Read more
June 1, T-CURX acquires Pantherna Therapeutics to accelerate clinical translation of its non-viral in vivo CAR-T strategies
Read more
May 28-29, T-CURX invited to present at 7th International CGT China Summit in Suzhou, China
Read more
May 4-6, 2026. T-CURX to participate at BioEquity conference 2026 in Prague, Czech Republic
Read more
April 28, 2026. T-CURX, Kytopen and Fraunhofer IZI establish a center of excellence to develop advanced, non-viral cell therapies
Read more
Feb 8, 2026. T-CURX invited to present at the 4th Dubai Stem Cell congress 2026
Read more
